Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/2032
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSIMOOYA, O. O.-
dc.contributor.authorADEROUNMUt, A. FADEKE-
dc.contributor.authorSALAKO, L. A.-
dc.date.accessioned2024-07-01T11:33:52Z-
dc.date.available2024-07-01T11:33:52Z-
dc.date.issued1988-
dc.identifier.citationAfr. J. Med. med Sci (1988) 17.3-7en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/2032-
dc.descriptionArticleen_US
dc.description.abstractThe schizontocidal effect of chloroquine was compared to that of amodiaquine in vivo and mefloquine in vitro. In the in-vivo study, 32 patients were randomly given chloroquine whilst 29 received amodiaquine. The mean parasite clearance time was 2.5 days for chloroquine and 2.4 days for amodiaquine. These times were not significantly different. The cure rate in both groups up to day 14 was 100%. In the in-vitro study, three isolates of Plasmodium falciparum were compared for their sensitivity to chloroquine and mefloquine. In all three isolates schizogony was inhibited at a concentration of 0.8 x 10"6 mol/l of either drug. It was concluded that chloroquine is still an effective schizontocidc and should remain the drug of choice for the treatment of P. falciparum in the Ibadan area.en_US
dc.description.sponsorshipCOLLEGE OF MEDICINEen_US
dc.language.isoenen_US
dc.publisherBLACKWELL SCIENTIFIC PUBLICATIONSen_US
dc.subjectmefloquimeen_US
dc.subjectpatientsen_US
dc.subjectparasiteen_US
dc.subjectamodiaquineen_US
dc.subjectschizontocidal effect of chloroquineen_US
dc.subjectPlasmodium falciparumen_US
dc.titleSensitivity of Plasmodium falciparum to chloroquine, amodiaquine and mefloquine in Ibadan, Nigeriaen_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Simooya et al_Sensitivity_1988.pdfArticle5.76 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.